Series of New Cationic Iridium(III) Complexes with Tunable Emission Wavelength and Excited State Properties: Structures, Theoretical Calculations, and Photophysical and Electrochemical Properties
Citations Over TimeTop 1% of 2006 papers
Abstract
A series of new cationic iridium(III) complexes [Ir(piq)2(N/\N)]+PF6- (1-6) (piq =1-phenyl-isoquinoline) containing N/\N ligands with different conjugated lengths were synthesized, where the six N/\N ligands were bipyridine, phenanthroline, 2-pyridyl-quinoline, 2,2'-biquinoline, 1,1'-biisoquinoline, and 2-(2-quniolinyl)quinoxaline. Single-crystal X-ray diffraction spectra of three complexes were studied, and the iridium(III) centers were found to adopt a distorted octahedral coordination geometry with cis metalated carbons and trans nitrogen atoms. UV-vis, photoluminescence, cyclic voltammetry, and theoretical calculations were employed for studying the photophysical and electrochemical properties. And the excited-state properties were investigated in detail. The excited state of complexes is complicated and contains triplet metal-to-ligand charge transfer (3MLCT), triplet ligand-to-ligand charge transfer (3LLCT), and ligand-centered (cyclometalated) (3LC) transitions simultaneously. Importantly, the emission wavelength can be tuned significantly from 586 to 732 nm by changing the conjugated length of N/\N ligands.
Related Papers
- → Exploitation of a Very Strongly σ‐Donating SnII Ligand: Synthesis of a Homoleptic, Octahedral NiIV Complex(2008)14 cited
- → Homoleptic ‘sandwich’ complexes of substituted tris(methimazolyl)borate ligands with ruthenium, rhodium and palladium(2013)5 cited
- → Recent Advances on the Synthesis, Reactions and Evaluation of the Pharmacological Properties of Quinoxaline, Quinoxaline-2-One and Quinoxaline-2,3-Dione(2021)1 cited
- → Structures and Reactivities of Organocopper Compounds(2002)23 cited
- → ChemInform Abstract: A Novel Route to Isoquinoline[2,1‐g][1,6]naphthyridine, Pyrazolo[5,1‐a]isoquinoline and Pyridazino[4′,5′:3,4]pyrazolo[5,1‐a]isoquinoline Derivatives with Evaluation of Antitumor Activities.(2013)